Reactive oxygen species-induced expression of B cell activating factor (BAFF) is independent of toll-like receptor 4 and myeloid differentiation primary response gene 88

Biomolecules and Therapeutics

Volumn 17, Issue 2, 2009, Pages 144-150

  Kim, Hyun Sun ^a   Moon, Eun Yi ^a  

^a Sejong University   (South Korea)

Author keywords

BAFF; MyD88; ROS; TLR4

Indexed keywords

B CELL ACTIVATING FACTOR; MYELOID DIFFERENTIATION FACTOR 88; REACTIVE OXYGEN METABOLITE; TOLL LIKE RECEPTOR 4;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CULTURE MEDIUM; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; SPLEEN CELL;

MUS;

EID: 69549121680     PISSN: 19769148     EISSN: None     Source Type: Journal    
DOI: 10.4062/biomolther.2009.17.2.144     Document Type: Article

References (36)

1. Adachi, O., Kawai, T., Takeda, K., Matsumoto, M., Tsutsui, H., Sakagami, M., Nakanishi, K. and Akira, S. (1998). Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 9, 143-150. (Pubitemid 28361303)
2. Akira, S., Yamamoto, M. and Takeda, K. (2003). Role of adapters in Toll-like receptor signaling. Biochem. Soc. Trans. 31, 637-642. (Pubitemid 36750746)
3. Asehnoune, K., Strassheim, D., Mitra, S., Kim, J. Y. and Abraham, E. (2004). Involvement of reactive oxygen species in Toll-like receptor 4-dependent activation of NF-kappa B. J. Immunol. 172, 2522-2529. (Pubitemid 38182403)
4. Baeuerle, P. A. and Henkel, T. (1994). Function and activation of NF-kappa B in the immune system. Annu. Rev. Immunol. 12, 141-179. (Pubitemid 2081202)
5. Choi, M. H., Lee, I. K., Kim, G. W., Kim, B. U., Han, Y. H., Yu, D. Y., Park, H. S., Kim, K. Y., Lee, J. S., Choi, C., Bae, Y. S., Lee, B. I., Rhee, S. G. and Kang, S. W. (2005). Regulation of PDGF signalling and vascular remodelling by peroxiredoxin II. Nature. 435, 347-353. (Pubitemid 40745544)
6. Corrigan, C. (2004). Mechanisms of intrinsic asthma. Curr. Opin. Allergy Clin. Immunol. 4, 53-56.
7. Dhar, A., Young, M. R. and Colburn, N. H. (2002). The role of AP-1, NF-kappaB and ROS/NOS in skin carcinogenesis: the JB6 model is predictive. Mol. Cell Biochem. 234-235, 185-193. (Pubitemid 34777856)
8. Flohe, L., Brigelius-Flohe, R., Saliou, C., Traber, M. G. and Packer, L. (1997). Redox regulation of NF-kappa B activation. Free Radic. Biol. Med. 22, 1115-1126.
9. Fu, L., Lin-Lee, Y. C., Pham, L. V., Tamayo, A., Yoshimura, L. and Ford, R. J. (2006). Constitutive NF-kappaB and NFAT activation leads to stimulation of the BLyS survival pathway in aggressive B-cell lymphomas. Blood 107, 4540-4548. (Pubitemid 43801383)
10. Gerritsen, M. E., Williams, A. J., Neish, A. S., Moore, S., Shi, Y. and Collins, T. (1997). CREB-binding protein/p300 are transcriptional coactivators of p65. Proc. Natl. Acad. Sci. USA. 94, 2927-2932. (Pubitemid 27157241)
11. Han, Y. H., Kim, H. S., Kim, J. M., Kim, S. K., Yu, D. Y. and Moon, E. Y. (2005). Inhibitory role of peroxiredoxin II (Prx II) on cellular senescence. FEBS Lett. 579, 4897-4902. (Pubitemid 41218682)
12. Han, Y. H., Kwon, J. H., Yu, D. Y. and Moon, E. Y. (2006). Inhibitory effect of peroxiredoxin II (Prx II) on Ras-ERK-NFkappaB pathway in mouse embryonic fibroblast (MEF) senescence. Free Radic. Res. 40, 1182-1189.
13. Hollingsworth, J. W., Whitehead, G. S., Lin, K. L., Nakano, H., Gunn, M. D., Schwartz, D. A. and Cook, D. N. (2006). TLR4 signaling attenuates ongoing allergic inflammation. J. Immunol. 176, 5856-5862.
14. Hultmark, D. (1994). Macrophage differentiation marker MyD88 is a member of the Toll/IL-1 receptor family. Biochem. Biophys. Res. Commun. 199, 144-146.
15. Janknecht, R. and Hunter, T. (1996). Transcription. A growing coactivator network. Nature 383, 22-23.
16. Janknecht, R. and Hunter, T. (1996). Versatile molecular glue. Transcriptional control. Curr. Biol. 6, 951-954.
17. Litinskiy, M. B., Nardelli, B., Hilbert, D. M., He, B., Schaffer, A., Casali, P. and Cerutti, A. (2002). DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat. Immunol. 3, 822-829. (Pubitemid 35049432)
18. Lord, K. A., Hoffman-Liebermann, B. and Liebermann, D. A. (1990). Nucleotide sequence and expression of a cDNA encoding MyD88, a novel myeloid differentiation primary response gene induced by IL6. Oncogene 5, 1095-1097. (Pubitemid 20220258)
19. Mackay, F., Schneider, P., Rennert, P. and Browning, J. (2003). Baff and april: a tutorial on B cell survival. Annu. Rev. Immunol. 21, 231-264. (Pubitemid 37174532)
20. Mackay, F., Woodcock, S. A., Lawton, P., Ambrose, C., Baetscher, M., Schneider, P., Tschopp, J. and Browning, J. L. (1999). Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J. Exp. Med. 190, 1697-1710. (Pubitemid 30002351)
21. Mates, J. M., Perez-Gomez, C. and Nunez de Castro, I. (1999). Antioxidant enzymes and human diseases. Clin. Biochem. 32, 595-603.
22. Moon, E. Y. (2008). Serum deprivation enhances apoptotic cell death by increasing mitochondrial enzyme activity. Biomol. Ther. 16, 1-8.
23. Moon, E. Y., Han, Y. H., Lee, D. S., Han, Y. M. and Yu, D. Y. (2004). Reactive oxygen species induced by the deletion of peroxiredoxin II (PrxII) increases the number of thymocytes resulting in the enlargement of PrxII-null thymus. Eur. J. Immunol. 34, 2119-2128.
24. Moon, E. Y., Kang, J. S., Han, S. H., Yang, K. H., Pyo, S., Lee, M. Y., Lee, H. K. and Yu, D. Y. (2008). Differential role of peroxiredoxin II (PrxII) on the expression of toll-like receptor 4 (TLR4) and B-cell activating factor (BAFF) in ovalbumin (OVA)-induced mouse asthma. Int. Immunopharmacol. 8, 935-944.
25. Moon, E. Y., Lee, J. H., Oh, S. Y., Ryu, S. K., Kim, H. M., Kwak, H. S. and Yoon, W. K. (2006). Reactive oxygen species augment B-cell-activating factor expression. Free Radic. Biol. Med. 40, 2103-2111. (Pubitemid 43903097)
26. Muzio, M., Ni, J., Feng, P. and Dixit, V. M. (1997). IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling. Science 278, 1612-1615. (Pubitemid 27516277)
27. Ostergaard, P. A. (1985). Non-IgE-mediated asthma in children. Acta. Paediatr. Scand. 74, 713-719.
28. Perkins, N. D., Felzien, L. K., Betts, J. C., Leung, K., Beach, D. H. and Nabel, G. J. (1997). Regulation of NF-kappaB by cyclin-dependent kinases associated with the p300 coactivator. Science 275, 523-527. (Pubitemid 27051906)
29. Rackeman, F. M. (1947). A working classification of asthma. Am. J. Med. 33, 601-606.
30. Sanlioglu, S., Williams, C. M., Samavati, L., Butler, N. S., Wang, G., McCray, P. B. Jr., Ritchie, T. C., Hunninghake, G. W., Zandi, E. and Engelhardt, J. F. (2001). Lipopolysaccharide induces Rac1-dependent reactive oxygen species formation and coordinates tumor necrosis factor-alpha secretion through IKK regulation of NF-kappa B. J. Biol. Chem. 276, 30188-30198. (Pubitemid 37385100)
31. Schiemann, B., Gommerman, J. L., Vora, K., Cachero, T. G., Shulga-Morskaya, S., Dobles, M., Frew, E. and Scott, M. L. (2001). An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. Science 293, 2111-2114. (Pubitemid 32848063)
32. Schneider, P., MacKay, F., Steiner, V., Hofmann, K., Bodmer, J. L., Holler, N., Ambrose, C., Lawton, P., Bixler, S., Acha-Orbea, H., Valmori, D., Romero, P., Werner-Favre, C., Zubler, R. H., Browning, J. L. and Tschopp, J. (1999). BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J. Exp. Med. 189, 1747-1756. (Pubitemid 29272691)
33. Tai, Y. T., Li, X. F., Breitkreutz, I., Song, W., Neri, P., Catley, L., Podar, K., Hideshima, T., Chauhan, D., Raje, N., Schlossman, R., Richardson, P., Munshi, N. C. and Anderson, K. C. (2006). Role of B-cell-activating factor in adhesion and growth of human multiple myeloma cells in the bone marrow microenvironment. Cancer Res. 66, 6675-6682. (Pubitemid 44085624)
34. Toledano, M. B. and Leonard, W. J. (1991). Modulation of transcription factor NF-kappa B binding activity by oxidationreduction in vitro. Proc. Natl. Acad. Sci. USA. 88, 4328-4332. (Pubitemid 21914533)
35. Wesche, H., Henzel, W. J., Shillinglaw, W., Li, S. and Cao, Z. (1997). MyD88: an adapter that recruits IRAK to the IL-1 receptor complex. Immunity 7, 837-847. (Pubitemid 28064897)
36. Zhang, H., Spapen, H., Nguyen, D. N., Benlabed, M., Buurman, W. A. and Vincent, J. L. (1994). Protective effects of N-acetyl-L-cysteine in endotoxemia. Am. J. Physiol. 266, H1746-1754.